Close

Press Releases

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked deeper biological insights. By integrating structure prediction, molecular modeling,...

Syntegon Reports Accelerated Growth in 2024 Results

Syntegon delivers record results in 2024 New strategy fuels accelerated growth following CEO transition in late 2023 Order intake increased by 11% to 1.8 billion EUR and revenue grew by 7% to 6 billion EUR Strong EBITDA improvement by 15%...

Agilent Inaugurates India Solution Center to Accelerate Innovation and Expand the Frontiers of Science.

Integrated Facility to Deliver End-to-End, Customized Workflows Across Life Sciences, Diagnostics, and Applied Markets India –  Agilent today announced the opening of its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana. Designed to provide integrated solutions,...

ACG Packaging Materials Earns SBTi Emission Target Nod

Mumbai, India, May 7, 2025 ACG Packaging Materials, a leading global supplier of integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, has taken a significant step forward in its sustainability journey as the Science Based Targets initiative (SBTi)...

Kindeva bolsters executive team with Chief Quality Officer appointment

A global CDMO and drug delivery expert, has today announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy. With a proven track record in safely delivering treatments to patients across...

Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics

Thermo Fisher Scientific, a prominent figure in the scientific community, is utilising an advanced platform technology along with a new CHO K-1 cell line that can shorten the timeline for Investigational New Drug (IND) filing from 13 to nine...

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research

Martigny, Switzerland. Dijon, France – Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services (www.oncodesign-services.com), a leading CRO specialized in drug discovery and preclinical services, announce the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read